These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3973964)

  • 21. Antibody responses to mumps virus proteins in natural mumps infection and after vaccination with live and inactivated mumps virus vaccines.
    Julkunen I; Väänänen P; Penttinen K
    J Med Virol; 1984; 14(3):209-19. PubMed ID: 6389772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity.
    Hirsch RL; Wolinsky JS; Winkelstein JA
    Arch Virol; 1986; 87(3-4):181-90. PubMed ID: 3947239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay (ELISA) for mumps virus antibodies.
    Popow-Kraupp T
    J Med Virol; 1981; 8(2):79-88. PubMed ID: 7028918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant mumps viruses expressing the batMuV fusion glycoprotein are highly fusion active and neurovirulent.
    Krüger N; Sauder C; Hoffmann M; Örvell C; Drexler JF; Rubin S; Herrler G
    J Gen Virol; 2016 Nov; 97(11):2837-2848. PubMed ID: 27590163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive hemagglutination inhibition test for mumps antibody.
    Albrecht P; Klutch M
    J Clin Microbiol; 1981 May; 13(5):870-6. PubMed ID: 6972385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Avidity of IgG antibodies against mumps, parainfluenza 2 and Newcastle disease viruses after mumps infection.
    Lehtonen OP; Meurman OH
    J Virol Methods; 1986 Aug; 14(1):1-7. PubMed ID: 2429976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polypeptides of mumps virus.
    Jensik SC; Silver S
    J Virol; 1976 Feb; 17(2):363-73. PubMed ID: 943571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antibodies and interferon on mumps virus persistently infected L929 cells. Generation of variant viruses in the cells during incubation with monoclonal antibodies and interferon.
    Ito Y; Tsurudome M; Hishiyama M
    Arch Virol; 1986; 88(3-4):217-30. PubMed ID: 2423057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments.
    Williams JA; Gui L; Hom N; Mileant A; Lee KK
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differentiation of cerebrospinal immunoglobulins in mumps meningoencephalitis].
    Statz A; Felgenhauer K
    Monatsschr Kinderheilkd; 1987 May; 135(5):265-8. PubMed ID: 3614221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
    Liang M; Chu YK; Schmaljohn C
    Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent infection and measles meningoencephalitis in Syrian hamsters.
    Eliseeva IYa ; Ravkina LI; Karmysheva VYa
    Acta Virol; 1977 May; 21(3):222-7. PubMed ID: 18920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains.
    Rubin S; Mauldin J; Chumakov K; Vanderzanden J; Iskow R; Carbone K
    Vaccine; 2006 Mar; 24(14):2662-8. PubMed ID: 16309801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental mumps virus-induced hydrocephalus: viral neurotropism and neuronal maturity.
    Takano T; Takikita S; Shimada M
    Neuroreport; 1999 Aug; 10(11):2215-21. PubMed ID: 10439437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of viral glycoproteins in mumps-virus-dependent lymphocyte-mediated cytotoxicity in vitro.
    Härfast B; Orvell C; Alsheikhly A; Andersson T; Perlmann P; Norrby E
    Scand J Immunol; 1980; 11(4):391-400. PubMed ID: 7384752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme immunoassay of mumps virus in cell culture with peroxidase-labelled virus specific monoclonal antibodies and its application for determination of antibodies.
    van Tiel FH; Kraaijeveld CA; Baller J; Harmsen T; Oosterlaken TA; Snippe H
    J Virol Methods; 1988 Oct; 22(1):99-108. PubMed ID: 3058739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common peptide epitope in mumps virus nucleocapsid protein and MHC class II-associated invariant chain.
    Hyöty H; Parkkonen P; Rode M; Bakke O; Leinikki P
    Scand J Immunol; 1993 May; 37(5):550-8. PubMed ID: 7683440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of primary cytotoxic T cells in venous blood and cerebrospinal fluid of children with mumps meningitis.
    Kreth HW; Kress L; Kress HG; Ott HF; Eckert G
    J Immunol; 1982 Jun; 128(6):2411-5. PubMed ID: 6176633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
    Sun L; Chen Z; Yu L; Wei J; Li C; Jin J; Shen X; Lv X; Tang Q; Li D; Liang M
    Appl Microbiol Biotechnol; 2012 Oct; 96(2):357-66. PubMed ID: 22678022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.